1
|
Ogose A, Morita T, Hotta T, Kobayashi H,
Otsuka H, Hirata Y and Yoshida S: Brain metastases in
musculoskeletal sarcomas. Jpn J Clin Oncol. 29:245–247. 1999.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Fox BD, Patel A, Suki D and Rao G:
Surgical management of metastatic sarcoma to the brain. J
Neurosurg. 110:181–186. 2009. View Article : Google Scholar : PubMed/NCBI
|
3
|
Robert Schwartzman: Neurologic
Examination. 1st. Wiley-Blackwell; Oxford: 2006
|
4
|
Schag CC, Heinrich RL and Ganz PA:
Karnofsky performance status revisited: Reliability, validity, and
guidelines. J Clin Oncology. 2:187–193. 1984.
|
5
|
Hunter BC, Devaney KO, Ferlito A and
Rinaldo A: Alveolar soft part sarcoma of the head and neck region.
Ann Otol Rhinol Laryngol. 107:810–814. 1998. View Article : Google Scholar : PubMed/NCBI
|
6
|
Rosai J, Dias P, Parham DM, Shapiro DN and
Houghton P: MyoD1 protein expression in alveolar soft part sarcoma
as confirmatory evidence of its skeletal muscle nature. Am J Surg
Pathol. 15:974–981. 1991. View Article : Google Scholar : PubMed/NCBI
|
7
|
Smetana HF and Scott WF Jr: Malignant
tumors of nonchromaffin paraganglia. Mil Surg. 109:330–349.
1951.PubMed/NCBI
|
8
|
Uppal S, Aviv H, Patterson F, Cohen S,
Benevia J, Aisner S and Hameed M: Alveolar soft part sarcoma -
reciprocal translocation between chromosome 17q25 and Xp11. Report
of a case with metastases at presentation and review of the
literature. Acta Orthop Belg. 69:182–187. 2003.PubMed/NCBI
|
9
|
Williams A, Bartle G, Sumathi VP, Meis JM,
Mangham DC, Grimer RJ and Kindblom LG: Detection of ASPL/TFE3
fusion transcripts and the TFE3 antigen in formalin-fixed,
paraffin-embedded tissue in a series of 18 cases of alveolar soft
part sarcoma: Useful diagnostic tools in cases with unusual
histological features. Virchows Arch. 458:291–300. 2011. View Article : Google Scholar : PubMed/NCBI
|
10
|
Perry JR and Bilbao JM: Metastatic
alveolar soft part sarcoma presenting as a dural-based cerebral
mass. Neurosurgery. 1994.34:168–170. View Article : Google Scholar : PubMed/NCBI
|
11
|
Lewis AJ: Sarcoma metastatic to the brain.
Cancer. 61:593–601. 1988. View Article : Google Scholar : PubMed/NCBI
|
12
|
Reichardt P, Lindner T, Pink D,
Thuss-Patience PC, Kretzschmar A and Dörken B: Chemotherapy in
alveolar soft part sarcomas: What do we know? Eur J Cancer.
39:1511–1516. 2003. View Article : Google Scholar : PubMed/NCBI
|
13
|
Kummar S, Allen D, Monks A, Polley EC,
Hose CD, Ivy SP, Turkbey IB, Lawrence S, Kinders RJ, Choyke P, et
al: Cediranib for metastatic alveolar soft part sarcoma. J Clin
Oncol. 31:2296–2302. 2013. View Article : Google Scholar : PubMed/NCBI
|
14
|
Sleijfer S, Ballman K and Verweij J: The
future of drug development? Seeking evidence of activity of novel
drugs in small groups of patients. J Clin Oncol. 31:2246–2248.
2013. View Article : Google Scholar : PubMed/NCBI
|